Department of Radiation Oncology

Medicine and Dentistry

1. Radiation Therapy 100%
2. Overall Survival 37%
3. Hepatocellular Carcinoma 36%
4. Chemoradiotherapy 31%
5. Breast Cancer 27%
6. Recurrent Disease 26%
7. Proton Therapy 23%
8. Neoplasm 22%
9. Non Small Cell Lung Cancer 21%
10. Chemotherapy 21%
11. Survival Rate 14%
12. Progression Free Survival 14%
13. Intensity Modulated Radiation Therapy 13%
14. Median Follow Up 13%
15. Prognostic Factor 11%
16. Diseases 11%
17. Retrospective Study 11%
18. Disease Free Survival 11%
19. Radiation Oncology 10%
20. Hazard Ratio 9%
21. Cervical Cancer 9%
22. Rectum Cancer 8%
23. Chemoradiation Therapy 8%
24. Lymph Node Metastasis 8%
25. Abdominal Cancer 8%
26. Drug Megadose 7%
27. Prostate Cancer 7%
28. Treatment Outcome 7%
29. Positron Emission Tomography-Computed Tomography 7%
30. Esophageal Squamous Cell Carcinoma 7%
31. Tumor 7%
32. Lung Cancer 7%
33. Transcatheter Arterial Chemoembolization 6%
34. Arm 6%
35. Multivariate Analysis 6%
36. Magnetic Resonance Imaging 6%
37. Lymph Node 6%
38. Glioblastoma 6%
39. Quadrantectomy 6%
40. Computer Assisted Tomography 6%
41. Hypofractionated Radiotherapy 5%
42. Adjuvant Radiotherapy 5%
43. Malignant Neoplasm 5%
44. Stereotactic Body Radiation Therapy 5%
45. Phase II Trials 5%
46. Lung 5%
47. Cisplatin 5%
48. Pelvis 5%
49. Recurrence Free Survival 5%
50. Adjuvant Therapy 5%
51. Neoadjuvant Chemotherapy 5%
52. Conformal Radiotherapy 5%
53. External Beam Radiotherapy 5%